Concepedia

Richard Hajdu

RH

29

Publications

4.1K

Citations

24

H-Index

1982

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Richard Hajdu is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, medicine, and drug discovery.

Top concepts

Publications per year

1982–2016

29

Publications

29

Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists

Suzanne Mandala, Richard Hajdu, James D. Bergstrom et al. · Science · 2002 · 1.7K citations

, , +19

Mice Deficient in Sphingosine Kinase 1 Are Rendered Lymphopenic by FTY720

María L. Allende, Teiji Sasaki, Hiromichi Kawai et al. · Journal of Biological Chemistry · 2004 · 443 citations · Full text

Metabolism of Thienamycin and Related Carbapenem Antibiotics by the Renal Dipeptidase, Dehydropeptidase-I

H Kropp, Jon G. Sundelof, Richard Hajdu et al. · Antimicrobial Agents and Chemotherapy · 1982 · 338 citations · Full text

Immune Cell Regulation and Cardiovascular Effects of Sphingosine 1-Phosphate Receptor Agonists in Rodents Are Mediated via Distinct Receptor Subtypes

M J Forrest, S.-Y. Sun, Richard Hajdu et al. · Journal of Pharmacology and Experimental Therapeutics · 2004 · 332 citations

Preliminary animal pharmacokinetics of the parenteral antifungal agent MK-0991 (L-743,872)

Richard Hajdu, R Thompson, Jon G. Sundelof et al. · Antimicrobial Agents and Chemotherapy · 1997 · 167 citations · Full text

, , +17

Rows per page

1–5 of 29